Siân Fogden, Graphene Flagship01.24.19
As the drive to commercialize graphene continues, it is important that all safety aspects are thoroughly researched and understood. The Graphene Flagship project has a dedicated Work Package studying the impact of graphene and related materials on our health, as well as their environmental impact. This enables safety by design to become a core part of innovation.
Researches and companies are currently using a range of materials such as few layered graphene, graphene oxide and heterostructures. The first step to assess the toxicology is to fully characterize these materials. This work overviews the production and characterization methods, and considers different materials, which biological effects depend on their inherent properties.
“One of the key messages is that this family of materials has varying properties, thus displaying varying biological effects. It is important to emphasize the need not only for a systematic analysis of well-characterized graphene-based materials, but also the importance of using standardised in vitro or in vivo assays for the safety assessment,” said Bengt Fadeel, lead author of this paper working at Graphene Flagship partner Karolinska Institutet, Sweden.
“This review correlates the physicochemical characteristics of graphene and related materials to the biological effects. A classification based on lateral dimensions, number of layers and carbon-to-oxygen ratio allows us to describe the parameters that can alter graphene’s toxicology. This can orient future development and use of these materials,” explained Alberto Bianco, from Graphene Flagship partner CNRS, France and deputy leader of the Graphene Flagship Work Package on Health and Environment.
The paper gives a comprehensive overview of all aspects of graphene health and environmental impact, focusing on the potential interactions of graphene-based materials with key target organs including immune system, skin, lungs, cardiovascular system, gastrointestinal system, central nervous system, reproductive system, as well as a wide range of other organisms including bacteria, algae, plants, invertebrates, and vertebrates in various ecosystems.
“One cannot draw conclusions from previous work on other carbon-based materials such as carbon nanotubes and extrapolate to graphene. Graphene-based materials are less cytotoxic when compared to carbon nanotubes and graphene oxide is readily degradable by cells of the immune system,” said Fadeel.
Andrea C. Ferrari, science and technology officer of the Graphene Flagship and chair of its Management Panel, added that “understanding any potential Health and Environmental impacts of graphene and related materials has been at the core of all Graphene Flagship activities since day one. This review provides a solid guide for the safe use of these materials, a key step towards their widespread utilization as targeted by our innovation and technology roadmap.”
Reference:
Bengt Fadeel, Cyrill Bussy, Sonia Merino, Ester Vázquez, Emmanuel Flahaut, Florence Mouchet, Lauris Evariste, Laury Gauthier, Antti J. Koivisto, Ulla Vogel, Cristina Martín, Lucia G. Delogu, Tina Buerki-Thurnherr, Peter Wick, Didier Beloin-Saint-Pierre, Roland Hischier, Marco Pelin, Fabio Candotto Carniel, Mauro Tretiach, Fabrizia Cesca, Fabio Benfenati, Denis Scaini, Laura Ballerini, Kostas Kostarelos, Maurizio Prato, and Alberto Bianco. “Safety Assessment of Graphene-Based Materials: Focus on Human Health and the Environment.” ACS Nano 2018, 12, 10582−10620. DOI: 10.1021/acsnano.8b04758.
Researches and companies are currently using a range of materials such as few layered graphene, graphene oxide and heterostructures. The first step to assess the toxicology is to fully characterize these materials. This work overviews the production and characterization methods, and considers different materials, which biological effects depend on their inherent properties.
“One of the key messages is that this family of materials has varying properties, thus displaying varying biological effects. It is important to emphasize the need not only for a systematic analysis of well-characterized graphene-based materials, but also the importance of using standardised in vitro or in vivo assays for the safety assessment,” said Bengt Fadeel, lead author of this paper working at Graphene Flagship partner Karolinska Institutet, Sweden.
“This review correlates the physicochemical characteristics of graphene and related materials to the biological effects. A classification based on lateral dimensions, number of layers and carbon-to-oxygen ratio allows us to describe the parameters that can alter graphene’s toxicology. This can orient future development and use of these materials,” explained Alberto Bianco, from Graphene Flagship partner CNRS, France and deputy leader of the Graphene Flagship Work Package on Health and Environment.
The paper gives a comprehensive overview of all aspects of graphene health and environmental impact, focusing on the potential interactions of graphene-based materials with key target organs including immune system, skin, lungs, cardiovascular system, gastrointestinal system, central nervous system, reproductive system, as well as a wide range of other organisms including bacteria, algae, plants, invertebrates, and vertebrates in various ecosystems.
“One cannot draw conclusions from previous work on other carbon-based materials such as carbon nanotubes and extrapolate to graphene. Graphene-based materials are less cytotoxic when compared to carbon nanotubes and graphene oxide is readily degradable by cells of the immune system,” said Fadeel.
Andrea C. Ferrari, science and technology officer of the Graphene Flagship and chair of its Management Panel, added that “understanding any potential Health and Environmental impacts of graphene and related materials has been at the core of all Graphene Flagship activities since day one. This review provides a solid guide for the safe use of these materials, a key step towards their widespread utilization as targeted by our innovation and technology roadmap.”
Reference:
Bengt Fadeel, Cyrill Bussy, Sonia Merino, Ester Vázquez, Emmanuel Flahaut, Florence Mouchet, Lauris Evariste, Laury Gauthier, Antti J. Koivisto, Ulla Vogel, Cristina Martín, Lucia G. Delogu, Tina Buerki-Thurnherr, Peter Wick, Didier Beloin-Saint-Pierre, Roland Hischier, Marco Pelin, Fabio Candotto Carniel, Mauro Tretiach, Fabrizia Cesca, Fabio Benfenati, Denis Scaini, Laura Ballerini, Kostas Kostarelos, Maurizio Prato, and Alberto Bianco. “Safety Assessment of Graphene-Based Materials: Focus on Human Health and the Environment.” ACS Nano 2018, 12, 10582−10620. DOI: 10.1021/acsnano.8b04758.
